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ARTICLE OPEN
Genetic interaction of DISC1 and Neurexin in the development
of fruit ﬂy glutamatergic synapses
Himani Pandey1, Katia Bourahmoune1, Takato Honda1, Ken Honjo1, Kazuki Kurita1, Tomohito Sato1, Akira Sawa2 and
Katsuo Furukubo-Tokunaga1
Originally identiﬁed at the breakpoint of a (1;11)(q42.1; q14.3) chromosomal translocation in a Scottish family with a wide range of
mental disorders, the DISC1 gene has been a focus of intensive investigations as an entry point to study the molecular mechanisms
of diverse mental dysfunctions. Perturbations of the DISC1 functions lead to behavioral changes in animal models, which are
relevant to psychiatric conditions in patients. In this work, we have expressed the human DISC1 gene in the fruit ﬂy (Drosophila
melanogaster) and performed a genetic screening for the mutations of psychiatric risk genes that cause modiﬁcations of DISC1
synaptic phenotypes at the neuromuscular junction. We found that DISC1 interacts with dnrx1, the Drosophila homolog of the
human Neurexin (NRXN1) gene, in the development of glutamatergic synapses. While overexpression of DISC1 suppressed the total
bouton area on the target muscles and stimulated active zone density in wild-type background, a partial reduction of the dnrx1
activity negated the DISC1–mediated synaptic alterations. Likewise, overexpression of DISC1 stimulated the expression of a
glutamate receptor component, DGLURIIA, in wild-type background but not in the dnrx1 heterozygous background. In addition,
DISC1 caused mislocalization of Discs large, the Drosophila PSD-95 homolog, in the dnrx1 heterozygous background. Analyses with
a series of domain deletions have revealed the importance of axonal localization of the DISC1 protein for efﬁcient suppression of
DNRX1 in synaptic boutons. These results thus suggest an intriguing converging mechanism controlled by the interaction of DISC1
and Neurexin in the developing glutamatergic synapses.
npj Schizophrenia  (2017) 3:39 ; doi:10.1038/s41537-017-0040-6
INTRODUCTION
Since the discovery in a Scottish family with a (1;11)(q42.1; q14.3)
chromosomal translocation, the Disrupted-in-schizophrenia 1
(DISC1) gene has been studied as a key lead to investigate the
molecular pathways underlying the pathophysiology of major
mental disorders.1–5 In addition, perturbations of DISC1 functions
cause behavioral changes in animal models, which are relevant to
psychiatric conditions in patients.1–5 On the other hand, while
genetic studies have identiﬁed a large number of risk factor loci,6–9
they have not validated DISC1 as a common risk gene for sporadic
cases of schizophrenia deﬁned by the Diagnostic and Statistical
Manual of Mental Disorders.10–12 Given the intriguing complexity
that many of the genetic risk loci found with schizophrenia are
shared with other psychiatric diseases,13–15 systematic studies
with genetically tractable models that address the underlying
functional interactions between DISC1 and psychiatric risk factor
genes are warranted.
The fruit ﬂy (Drosophila melanogaster) has been used as a
powerful model for understanding cellular and molecular
mechanisms of neurological disorders.16,17 While animal models
for mental disorders have empirical and theoretical complications
in phenocopying human symptoms, a practical framework for
basic research on mental disorders has been proposed as
Research Domain Criteria that highlights the importance of
elucidating the underlying mechanisms of brain dysfunction at
the neurocircuit level.18–20 In this framework, mental disorders will
be studied at multiple biological and genetic levels using diverse
vertebrate and invertebrate models including fruit ﬂies. Accord-
ingly, several works have been reported using the ﬂy model to
investigate the mechanisms of mental disorders at the cellular,
molecular and genetic levels.21–28
For studying the molecular and genetic mechanisms of
synaptogenesis, the Drosophila neuromuscular junction (NMJ) is
an ideal system. The larval NMJs exhibit stereotypic synaptic
connections between the identiﬁable presynaptic motoneurons
and the speciﬁc postsynaptic muscles (Fig. 1a).29–31 Moreover, the
larval NMJs exhibit several important features in common with the
excitatory synapses in the vertebrate brain utilizing glutamate as
the major neurotransmitter in conjunction with the postsynaptic
ionotropic receptors that are homologous to the human
glutamate receptors.29,31,32 As with the vertebrate central synapse,
the synapses on the larval NMJs exhibit a dynamic feature with
organized series of boutons that are formed auxiliary or
eliminated on the target muscles during development and
plasticity.29,32,33
To analyze genetic interactions of DISC1 and psychiatric risk
factor genes, we have introduced the human DISC1 gene in fruit
ﬂies to be expressed in their nervous system. We showed
previously27 that overexpression of DISC1 (DISC1OE) suppresses
synaptogenesis at the developing larval NMJs. In this work, we
conducted a systematic screening for interacting risk factor genes
that cooperatively function with DISC1 to cause modiﬁcation of
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the synaptic phenotypes. We found that DISC1 interacts with
Neurexin (NRXN1), which encodes a family of synaptic adhesion
molecules implicated as a risk factor of various psychiatric
disorders including schizophrenia and autism spectrum disorders.
RESULTS
Genetic screening of DISC1 interactors in fruit ﬂy NMJs
To analyze the synaptic morphology, we performed immunologi-
cal staining of larval NMJs using a pan-neuronal antibody, anti-
horseradish peroxidase protein (HRP), and a synaptic vesicle
antibody, anti-Synaptotagmin (SYT), and determined the total
bouton area, the number of boutons, and the number of axonal
branch points that are made on the muscle 6/7 in the second
abdominal segment of early third instar larvae (116–120 h after
egg laying). Consistent with the previous study,27 DISC1OE caused
a reduction in total bouton area (analysis of variance (ANOVA) F (5,
85) = 7.49, p < 0.0001, +/+ DISC1 (−) vs. +/+ DISC1 (+), p = 0.0021,
by Tukey’s post hoc test) (Fig. 2g) but not the numbers of boutons
(ANOVA F (5, 82) = 3.19, p = 0.0111, +/+ DISC1 (−) vs. +/+ DISC1 (+),
p = 0.9216, by Tukey’s post hoc test) (Fig. 2h) and axonal branch
points (ANOVA F (5, 84) = 7.08, p < 0.0001, +/+ DISC1 (−) vs. +/+
DISC1 (+), p = 0.1536, by Tukey’s post hoc test) (Fig. 2i) in the wild-
type background. Based on this anatomical phenotype, we then
performed a genetic screening for psychiatric risk gene mutations
that modiﬁed the DISC1OE synaptic phenotype. Brieﬂy, we
expressed DISC1 in the heterozygous background of the ﬂy
mutations and compared their synaptic phenotypes against the
DISC1OE phenotype in the wild-type background (Fig. 1b).
Among the genes identiﬁed in this screening, a mutation of
dnrx1 (dnrx1d08766), the Drosophila homolog34–39 of the human
Neurexin (NRXN1), caused an modiﬁcation of the DISC1OE
phenotype in the developing NMJs (Fig. 2a–i). Although the
dnrx1d08766 mutation did not alter synaptic structures in the
heterozygous background (total bouton area: ANOVA F (5, 85) =
7.49, p < 0.0001, +/+ DISC1 (−) vs. dnrx1/+ DISC1 (−), p = 0.9853, by
Tukey’s post hoc test) (Fig. 2g) (number of boutons: ANOVA F (5,
82) = 3.19, p = 0.0111, +/+ DISC1 (−) vs. dnrx1/+ DISC1 (−), p =
0.0901, by Tukey’s post hoc test) (Fig. 2h) (number of branch
points: ANOVA F (5, 84) = 7.08, p < 0.0001,+/+ DISC1 (−) vs. dnrx1/
+ DISC1 (−), p = 0.9265, by Tukey’s post hoc test) (Fig. 2i), it failed
DISC1OE to suppress synaptic bouton area in the heterozygous
background (ANOVA F (5, 85) = 7.49, p < 0.0001, dnrx1/+ DISC1 (−)
vs. dnrx1/+ DISC1 (+), p = 0.8366, by Tukey’s post hoc test)
(Fig. 2g). Moreover, DISC1OE caused reductions in the number of
axonal branch points in the dnrx1d08766/+ heterozygous back-
ground (ANOVA F (5, 84) = 7.08, p < 0.0001, dnrx1/+ DISC1 (−) vs.
dnrx1/+ DISC1 (+), p = 0.0333, by Tukey’s post hoc test) (Fig. 2i)
resulting in a signiﬁcant suppression from the wild type (p <
0.0001, +/+ DISC1 (−) vs. dnrx1/+ DISC1 (+), p = 0.0009, by Tukey’s
post hoc test) (Fig. 2i). On the other hand, although the group as a
whole shows a difference (ANOVA F (5, 82) = 3.19, p = 0.0111),
DISC1OE did not alter the numbers of the synaptic boutons in both
the wild-type (+/+ DISC1 (−) vs. +/+ DISC1 (+), p = 0.9216, by
Tukey’s post hoc test) and the dnrx1 d08766/+ heterozygous
backgrounds (dnrx1/+ DISC1 (−) vs. dnrx1/+ DISC1 (+), p = 0.9993,
by Tukey’s post hoc test) (Fig. 2h).
To further investigate the genetic interaction between DISC1
and dnrx1, we analyzed whether a similar modiﬁcation of the
DISC1OE synaptic phenotype was caused by a partial suppression
of DNRX1 by RNA interference (RNAi). One of the RNAi lines we
tested, P{TRiP. JF02652}, exhibited approximately 50% down-
regulation of the DNRX1 protein level (ANOVA F (2, 47) = 22.89,
p < 0.0001, +/+ vs. dnrx1 RNAi, p < 0.0001, by Tukey’s post hoc
test) (Fig. 2l), which was comparable to the downregulation
observed in the dnrx1d08766/+ heterozygotes (dnrx1/+ vs. dnrx1
RNAi, p = 0.7833, by Tukey’s post hoc test) (Fig. 2l). As was the case
for the dnrx1d08766/+ heterozygotes, dnrx1 RNAi did not alter the
synaptic morphology on its own (total bouton area: ANOVA F
(5, 85) = 7.49, p < 0.0001, +/+ DISC1 (−) vs. dnrx1 RNAi DISC1 (−), p
= 0.7443, by Tukey’s post hoc test) (Fig. 2g) (number of boutons:
ANOVA F (5, 82) = 3.19, p = 0.0111, +/+ DISC1 (−) vs. dnrx1 RNAi
DISC1 (−), p = 0.9909, by Tukey’s post hoc test) (Fig. 2h) (number of
branch points: ANOVA F (5, 84) = 7.08, p < 0.0001, +/+ DISC1 (−) vs.
dnrx1 RNAi DISC1 (−), p = 0.7223, by Tukey’s post hoc test) (Fig. 2i).
Moreover, DISC1OE with dnrx1 RNAi failed to reduce the total
bouton area (ANOVA F (5, 85) = 7.49, p < 0.0001, dnrx1 RNAi DISC1
(−) vs. dnrx1 RNAi DISC1 (+), p = 0.9569, by Tukey’s post hoc test)
(Fig. 2g) but caused a signiﬁcant reduction in the number of
axonal branch points (ANOVA F (5, 84) = 7.08, p < 0.0001, dnrx1
RNAi DISC1 (−) vs. dnrx1 RNAi DISC1 (+), p = 0.0276, by Tukey’s
post hoc test) (Fig. 2i), recapitulating the modiﬁcation of the
DISC1OE synaptic phenotype in the dnrx1d08766/+ heterozygotes.
To examine whether DISC1OE altered the expression of the
immunological markers used in the anatomical analyses, we
quantitated the signal intensities of SYT and HRP. The expression
level of neither protein was altered with DISC1OE in the wild-type,
dnrx1d08766/+, nor RNAi backgrounds (SYT: ANOVA F (5, 68) = 0.22,
p = 0.9550) (Fig. 2j) (HRP: ANOVA F (5, 68) = 1.72, p = 0.1423)
(Fig. 2k).
DISC1 stimulates active zone density in wild-type but not in dnrx1/
+ background
Neurexins are a family of synaptic adhesion molecules expressed
on presynaptic neurons and organize the formation and matura-
tion of both presynaptic and postsynaptic structures through
Fig. 1 Fruit ﬂy NMJs and screening of interacting genes. a
Schematic presentation and a confocal image of the fruit ﬂy larval
NMJs. The larval NMJs exhibit stereotypic synaptic connections
between the identiﬁable presynaptic motoneuron and the speciﬁc
postsynaptic muscles. Each of the presynaptic boutons made on the
target muscle is surrounded by an intricately convoluted post-
synaptic membrane structure called subsynaptic reticulum (SSR),
which contains scaffolding proteins and postsynaptic signaling
complexes. b Screening of interacting genes. Mutant ﬂies (+/CyO-
GFP; mutation/TM6B-GFP) of the fruit ﬂy homologue for a psychiatric
risk factor gene are crossed with the control (+/+; tubP-GAL4/TM6B-
GFP) or the DISC1OE (UAS-DISC1; tubP-GAL4/TM6B-GFP) ﬂies. The
phenotypes of the larval NMJs between the control (+/+; mutation/
tubP-GAL4) and DISC1OE (+/UAS-DISC1; mutation/tubP-GAL4) animals
were compared
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interactions with postsynaptic partners, such as Neuroligins
(NLGs).40–42 In the ﬂy NMJs, DNRX1 mostly localizes to the active
zone of presynaptic terminals and controls the formation of active
zone and postsynaptic structures.34–39
To further analyze the functional interactions of dnrx1 and
DISC1 in synaptogenesis, we examined active zone formation
using a presynaptic marker, Bruchpilot (BRP), which is the ﬂy
homolog of the vertebrate ELKS/CAST active zone proteins
essential for rapid synaptic vesicle release.43–46 In the wild-type,
DISC1OE stimulated the BRP level (ANOVA F (3, 87) = 32.73,
p < 0.0001, +/+ DISC1 (−) vs. +/+ DISC1 (+), p = 0.02, by Tukey’s
post hoc test) (Fig. 3e) and the active zone density (ANOVA F (3,
96) = 7.22, p = 0.0002, +/+ DISC1 (−) vs. +/+ DISC1 (+), p = 0.0049,
by Tukey’s post hoc test) (Fig. 3f). Both the BRP level (ANOVA F (3,
87) = 32.73, p < 0.0001, +/+ DISC1 (−) vs. dnrx1/+ DISC1 (−),
p < 0.0001, by Tukey’s post hoc test) (Fig. 3e) and the active zone
Fig. 2 Modiﬁcation of synaptic morphology with DISC1 in wild-type and dnrx1 heterozygous backgrounds. a–f Representative confocal
images. a, b w (CS10) control animals. c, d dnrx1d08766/+ heterozygotes. e, f dnrx1 RNAi driven by tubP-GAL4. NMJs on the muscle 6/7 in the
second abdominal segment were immunostained with anti-HRP (green) and anti-SYT (magenta) antibodies. Scale bar, 20 μm. g–i
Morphometric analysis of NMJs with (+) or without (−) DISC1 overexpression. g Quantiﬁcation of the total bouton area at the NMJs on the
muscle 6/7. h Quantiﬁcation of the number of boutons at the NMJs on the muscle 6/7. i Quantiﬁcation of the number of axonal branch points
at the NMJs on the muscle 6/7. j Quantiﬁcation of SYT expression level normalized to HRP. k Quantiﬁcation of HRP immunoreactivity. l
Quantiﬁcation of DNRX1 expression level in dnrx1d08766 heterozygous and RNAi NMJs. Data are means± SEM. *p< 0.05, **p< 0.01, ***p<
0.001, and ****p< 0.0001 by one-way ANOVA followed by the Tukey’s pot hoc test. Number of each sample is indicated at the bottom of the
bar. The statistical values are listed in Supplementary Table 1
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density (ANOVA F (3, 96) = 7.22, p = 0.0002, +/+ DISC1 (−) vs.
dnrx1/+ DISC1 (−), p = 0.0003, by Tukey’s post hoc test) (Fig. 3f)
were increased in the dnrx1d08766/+ heterozygous (DISC1 minus)
yet DISC1OE further stimulated the BRP level resulting in a
signiﬁcant increase from the wild-type (+/+ DISC1 (−) vs. dnrx1/
+ DISC1 (+), p < 0.0001, by Tukey’s post hoc test) (Fig. 3e).
By contrast, DISC1OE failed to increase the active zone density
in the dnrx1d08766/+ heterozygous background (dnrx1/+ DISC1 (−)
vs. dnrx1/+ DISC1 (+), p = 0.2355, by Tukey’s post hoc test)
(Fig. 3f).
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DISC1 stimulates glutamate receptor expression in wild-type but
not in dnrx1/+ background
In addition to presynaptic structures, Neurexins control post-
synaptic structures via trans-synaptic interaction with its partner
molecules.40–42 In particular, presynaptic Neurexins trans-
synaptically control postsynaptic α-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate (AMPA) glutamate receptor stabilization
through the interactions with postsynaptic binding partners, such
as leucine-rich-repeat-transmembrane-neuronal 2 protein and
NLG.47
To determine whether reduction of dnrx1 activity modiﬁed the
DISC1OE phenotype in post-synaptic cells, we investigated the
expression of Drosophila-glutamate-receptor-IIA (DGLURIIA), one
of the subunits of the Drosophila AMPA receptor postsynaptically
expressed at the larval NMJs.48–50 Of note, DISC1OE stimulated the
DGLURIIA level in the wild-type (ANOVA F (3, 83) = 96.4, p < 0.0001,
+/+ DISC1 (−) vs. +/+ DISC1 (+), p = 0.0216, by Tukey’s post hoc
test) (Fig. 3o) but not in the dnrx1d08766/+ heterozygous back-
ground (dnrx1/+ DISC1 (−) vs. dnrx1/+ DISC1 (+), p = 0.2194, by
Tukey’s post hoc test) (Fig. 3o), which resulted in a signiﬁcant
increase in the DGLURIIA level on its own (Fig. 3g–j) (+/+ DISC1 (−)
vs. dnrx1/+ DISC1 (−), p < 0.0001, by Tukey’s post hoc test)
(Fig. 3o).
DISC1 causes mislocalization of a postsynaptic density marker in
dnrx1/+ background
To further investigate the DISC1-dnrx1 interaction, we examined
the postsynaptic density specialization by immunological staining
for Discs large (DLG), a fruit ﬂy homolog of the mammalian
MAGUK proteins, SAP 97, SAP102, and PSD-95, that are critical for
postsynaptic assembly at glutamatergic synapses.51,52 It has been
shown that nul mutations of dnrx1 alter subcellular distribution of
DLG in the postsynaptic cells of the ﬂy NMJs.35 In the ﬂy NMJs,
DLG localizes to an intricately convoluted post-synaptic mem-
brane structure called subsynaptic reticulum (Figs. 1a and 3k),
which contains scaffolding proteins and postsynaptic signaling
complexes. While DISC1OE failed to stimulated DLG expression in
wild-type background (ANOVA F (3, 77) = 20.8, p < 0.0001, +/+
DISC1 (−) vs. +/+ DISC1 (+), p = 0.9911, by Tukey’s post hoc test)
(Fig. 3p), it upregulated the DLG level in the dnrx1d08766/+
heterozygous background (dnrx1/+ DISC1 (−) vs. dnrx1/+ DISC1
(+), p < 0.0001, by Tukey’s post hoc test) (Fig. 3p). Moreover,
DISC1OE caused diffuse DLG localization in the dnrx1d08766/+
heterozygous background (ANOVA F (3, 122) = 45.4, p < 0.0001,
+/+ DISC1 (−) vs. dnrx1/+ DISC1 (+), p < 0.0001, by Tukey’s post
hoc test) (Fig. 4) while normal peripheral DLG localization was
maintained in both dnrx1d08766/+ (DISC1 minus) (+/+ DISC1 (−) vs.
dnrx1/+ DISC1 (−), p = 0.99, by Tukey’s post hoc test) and DISC1OE
in the wild-type background (+/+ DISC1 (−) vs. dnrx1/+ DISC1 (−),
p = 0.9939, +/+ DISC1 (−) vs. +/+ DISC1 (+), p < 0.7128, by Tukey’s
post hoc test) (Fig. 4e).
DISC1 causes locomotor defects in dnrx1/+ background
To analyze the behavioral consequence of the alterations
observed at the NMJs, we examined larval locomotor activity
(Supplementary Table S1). Although DISC1OE did not cause
signiﬁcant effect on the average locomotion speed in the wild-
type background (ANOVA F (3, 75) = 5.798, p = 0.0013, +/+ DISC1
(−) vs. +/+ DISC1 (+), p = 0.194, by Tukey’s post hoc test)
(Supplementary Fig. S1A), it caused signiﬁcant reduction in the
average locomotion speed in the dnrx1d08766/+ heterozygous
background (+/+ DISC1 (−) vs. dnrx1/+ DISC1 (+), p = 0.0037, by
Tukey’s post hoc test) (Supplementary Fig. S1A). Similarly, DISC1OE
did not alter peak locomotion speed (highest speed marked in 1
min measurement) in the wild-type background (ANOVA F (3, 75)
= 8.879, p < 0.0001, +/+ DISC1 (−) vs. +/+ DISC1 (+), p = 0.1031, by
Tukey’s post hoc test) (Supplementary Fig. S1B) but caused
signiﬁcant reduction in the average locomotion speed in the
dnrx1d08766/+ heterozygous background (+/+ DISC1 (−) vs. dnrx1/
+ DISC1 (+), p = 0.0009, by Tukey’s post hoc test) (Supplementary
Fig. S1B).
Despite the diverse alterations at the NMJs and in the larval
locomotor activity, no difference was detected in the cell body
size in the ventral nerve cord (Supplementary Fig. S2A–D) (ANOVA
F (3, 189) = 2.04, p = 0.1101) (Supplementary Fig. S2E), suggesting
that the observed changes are not the consequences of the
undergrowth of the cognate motoneurons.
Presynaptic overexpression of DISC1 suppresses DNRX1 in NMJ
boutons
The result that DISC1OE caused mislocalization of a postsynaptic
density marker in the dnrx1/+ background in part mimicked the
dnrx1 phenotype and prompted us to address whether DISC1
suppressed the DNRX1 protein level in the synaptic boutons.
Intriguingly, DISC1OE with a ubiquitous driver (tubP-GAL4) caused
moderate but signiﬁcant reduction in the DNRX1 level (tubP DISC1
(−) vs. tubP DISC1 (+), p = 0.009, by Tukey’s post hoc test) (Fig. 5g)
while the expression level of the pan-neuronal marker HRP
remained unchanged (tubP DISC1 (−) vs. tubP DISC1 (+),
p = 0.5606, by Tukey’s post hoc test) (Fig. 5h). To determine
whether presynaptic or postsynaptic DISC1OE caused downregula-
tion of DNRX1, we then expressed DISC1 using either a neuron-
speciﬁc (elav-GAL4), or a muscle-speciﬁc (C57-GAL4) driver (Fig. 5g)
and found that neuron-speciﬁc but not muscle-speciﬁc DISC1OE
downregulated the DNRX1 level (elav DISC1 (−) vs. elav DISC1 (+),
p = 0.0331; C57 DISC1 (−) vs. C57 DISC1 (+), p = 0.6596, by Tukey’s
post hoc test).
Axonal localization of the DISC1 protein is crucial for efﬁcient
suppression of DNRX1
To analyze the underlying mechanism of the suppression of
DNRX1, we expressed a series of DISC1 deletion constructs27
(Fig. 6a) and assessed the DNRX1 protein level in synaptic boutons
(Fig. 6b–h). Intriguingly, DISC1 (1–597), which corresponds to the
Scottish family truncation with a prominent axonal localization,27
Fig. 3 Expression of presynaptic and postsynaptic proteins in NMJ boutons. a–d Active zone formation with or without DISC1 overexpression.
Representative confocal images. a, b w (CS10) control animals. c, d dnrx1d08766/+ heterozygotes. Larval NMJs were immunostained with anti-
HRP (green) and anti-BRP (magenta) antibodies. Scale bar, 20 μm. e Quantiﬁcation of BRP expression level in the muscle 6/7 boutons
normalized to HRP immunoreactivity. f Quantiﬁcation of active zone density as determined by the number of BRP puncta per bouton area. g–j
Expression of DGLURIIA with or without DISC1 overexpression. Representative confocal images. g, h w (CS10) control animals. i, j dnrx1d08766/+
heterozygotes. Larval NMJs were immunostained with anti-HRP (green) and anti-DGLURIIA (magenta) antibodies. Scale bar, 20 μm. k–n
Expression of DLG with or without DISC1 overexpression. Representative confocal images. k, l w (CS10) control animals. m, n dnrx1d08766/+
heterozygotes. Larval NMJs were immunostained with anti-HRP (green) and anti-DLG (magenta) antibodies. Scale bar, 20 μm. o Quantiﬁcation
of DGLURIIA expression level in the muscle 6/7 boutons normalized to HRP immunoreactivity. p Quantiﬁcation of DLG expression level in the
muscle 6/7 boutons normalized to HRP immunoreactivity. Data are means± SEM. *p< 0.05, **p< 0.01, ***p< 0.001, and ****p< 0.0001 by
one-way ANOVA followed by the Tukey’s pot hoc test. Number of each sample is indicated at the bottom of the bar. The statistical values are
listed in Supplementary Table 1
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Fig. 4 Quantitative analysis of DLG localization in NMJ boutons. a–d Representative DISC1OE bouton images in the control and dnrx1d08766/+
heterozygous larvae. Larval NMJ boutons were immunostained with anti-HRP (green) and anti-DLG (magenta) antibodies. Right panels show
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signals in the NMJ boutons. Data are means± SEM. ****p< 0.0001 by one-way ANOVA followed by the Tukey’s pot hoc test. Number of each
sample is indicated at the bottom of the bar. The statistical values are listed in Supplementary Table 1
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exhibited stronger suppression of DNRX1 than the full-length
DISC1 (ANOVA F (5, 87) = 100.6, p < 0.0001, FL (1–854) vs. 1–597, p
= 0.0001, by Dunnett’s post hoc test against FL) (Fig. 6d, h), while
further removal of the protein domains (DISC1(1–402)) reverted
the suppressing activity similar to the full-length (FL(1–854))
protein level (FL (1–854) vs. 1–402, p = 0.1108, by Dunnett’s post
hoc test against FL) (Fig. 6e, h). Notably, DISC1 (1–402) lacks the
nuclear export signal with weak axonal localization,27 suggesting
the importance of axonal targeting over nuclear localization for
the suppression of the synaptic DNRX level. Consistently, DISC1
(mtNLS1), which is exclusively localized to the cytoplasm with
robust axonal targeting,22,27 exhibited strong DNRX1 suppression
(FL (1–854) vs. mtNLS1, p = 0.0001, by Dunnett’s post hoc test
against FL) (Fig. 6f, h) while further removal of the amino-terminal
domains (DISC1 (291–854)) including the PDE4 and GSK3β binding
motifs reverted the suppressing activity similar to the full-length
protein level (FL (1–854) vs. 291–854, p = 0.0688, by Dunnett’s post
hoc test against FL) (Fig. 6g, h). On the other hand, none of the
DISC1 derivatives caused an alteration in the expression level of
the pan-neuronal marker HRP used as an internal control (ANOVA
F (5, 87) = 1.79, p = 0.1224) (Fig. 6i).
DISCUSSION
In this paper, we have shown that DISC1 interacts with a
psychiatric risk factor gene, dnrx1, the Drosophila homolog of
the human NRXN1,40–42 in the glutamatergic synapses on the
larval NMJs. While DISC1OE upregulated the expression of the
ELKS/CAST protein BRP43–46 in presynaptic neurons in both the
wild-type and the dnrx1 heterozygous backgrounds, reduction of
dnrx1 suppressed DISC1-mediated stimulation of active zone
density. DISC1OE also upregulated expression of DGLURIIA, a
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component of the AMPA receptor expressed postsynaptically in
the ﬂy muscle,48–50 but failed to do so in the dnrx1 heterozygous
background. On the other hand, reduction of dnrx1 potentiated
DISC1 to stimulate the expression of DLG, the Drosophila homolog
of PSD-95, which controls postsynaptic density assembly.51,52
Moreover, DISC1OE caused diffuse DLG localization in the
dnrx1d08766/+ heterozygous background. We have also shown
that DISC1OE in presynaptic but not postsynaptic cells suppressed
the DNRX1 expression in the synaptic boutons. Analyses with a
series of DISC1 domain deletions have revealed that removal of a
carboxyl-terminal domain (DISC1 (1–597),27 which corresponds to
the Scottish family truncation, resulted in stronger suppression of
DNRX1 than the full-length protein. Likewise, a mutation of the
nuclear localization signal (mtNLS1), which leads to exclusive
cytoplasmic localization of the DISC1 protein with robust axonal
targeting,27 resulted in a stronger suppression.
Increasing lines of evidences suggest that aberrant synaptic
development and plasticity have important roles in the etiology of
various mental disorders.7–9,53 In this study, we have found that
dnrx1 exhibits functional interactions with DISC1 in the glutama-
tergic synapses at the larval NMJs. Notably, the observed
mislocalization of DLG caused by DISC1OE in the dnrx1d08766/+
background is reminiscent of the mislocalization phenotype
described for dnrx1 and dnlg1 double mutants.35 In addition, we
have also identiﬁed dnlg1,54,55 the fruit ﬂy homolog of the human
NLG1,40–42,56,57 as another interacting risk factor gene that
modiﬁes the functions of DISC1 in glutamatergic synapses
(P. H. and K. F. T., in preparation).
Although we have shown that partial reductions of the dnrx1
activity led to modiﬁcation of the DISC1OE synaptic phenotypes
both at the morphological and molecular levels, we have not been
able to show direct interaction between the DNRX1 and DISC1
proteins. Since the comprehensive DISC1 interactome studies also
fail to identify NRXN1 as a direct interacting partner,3,4,58–60 we
would rather speculate complex converging interactions of DISC1
and NRXN1 in glutamatergic synapses involving trans-synaptic
interactions between the presynaptic and postsynaptic cells that
cause a partial suppression of the DNRX1 protein level in the
boutons. In line with this notion, a recent study61 suggests that
Neurexin–NLG complex might regulate the DISC1-containing
Kalirin-7/Rac1 (RAS-related C3-botulinum toxin substrate 1) signal
complex through the interaction of Kalirin-7 and NLG. Further
studies are warranted to examine the interaction between the
NRXN1 and DSIC1 proteins in the nervous system development.
Mediating adhesive interactions between presynaptic and
postsynaptic cells, Neurexins and NLGs are critical molecules for
the precise organization and alignment of synaptic compartments
and molecular complexes.40–42 In presynaptic cells, Neurexins bind
directly to the scaffolding proteins CASK (calcium/calmodulin
dependent serine protein kinase) and MINT1 (Munc-18-interacting
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1) via PDZ (PSD-95 DLG Zonula occludens 1) domain interactions,
and indirectly recruit elements of the presynaptic release
machinery.40,41 Presynaptic Neurexins trans-synaptically control
postsynaptic AMPA receptor stabilization through interaction with
its postsynaptic partners such as LRRTM2 and NLGs,47 which in
turn interact with PDZ domain proteins such as PSD-95 in
postsynaptic neurons.40,41 It has been shown that DISC1 regulates
postsynaptic spine morphology and AMPA-type glutamate
receptor expression via interaction with PSD-95.59,60 It is also
noteworthy that the expression of NRXN1 and NRXN3 are
dysregulated in a mutant mouse line carrying an L100P DISC1
missense mutation.62 These results as a whole suggest an
intriguing convergence of intracellular signaling networks
mediated by DISC1 and NRXN1 in the development and plasticity
of glutamatergic synapses.
NRXN1 has been identiﬁed as a risk factor gene for diverse
psychiatric disorders including schizophrenia and autism spec-
trum disorders.40,63,64 By analyzing the genetic interactions in fruit
ﬂy glutamatergic synapses, we have identiﬁed a novel interaction
between DISC1 and a synaptic cell adhesion molecule that
organizes trans-synaptic structures and functions. On the other
hand, it should be noted that our study utilized a gain-of-function
approach expressing the human DISC1 protein in a heterologous
background. Further studies including loss-of-function studies in
mammalian models are warranted as are epistasis studies of
human subjects. Recent progress using patient-derived induced
pluripotent cells65,66 would also help to identify the molecular
process co-regulated by NRXN1 and DISC1 involved in the
pathophysiology of neuropsychiatric abnormalities.
MATERIALS AND METHODS
Fly stocks
A white (w) stock ten times outcrossed with Canton S (w (CS10)) was used
as the standard stock. Construction of transgenic ﬂies carrying UAS-DISC1
transgene including DISC1 (1-597) and DISC1 (mNLS1) has been described
previously.22,27 To ensure homogeneous genetic background, all ﬂy stocks
were outcrossed to w (CS10) at least ﬁve times. The following stocks were
obtained from the Bloomington Stock Center (Bloomington, IN, USA):
dnrx1d08766, dnrx1 RNAi P{TRiP. JF02652}, and GAL4 drivers (tubP-GAL4, elav-
GAL4, and C57-GAL4). All stocks were raised at 25 °C on a standard ﬂy food.
Genetic screening
For the screening, mutant lines were balanced with a double balancer
stock (w/w; Sp / CyO Act-GFP; Pr Dr/ TM6B ubi-GFP). The resulting progeny
carrying the mutation were then crossed either with control (w;+; tubP-
GAL4/TM6B ubi-GFP) or with DISC1OE (w; UAS-DISC1(CS10)6-6(II); tubP-GAL4/
TM6B ubi-GFP) ﬂies. Larvae were raised at 25 ˚C, and non-GFP animals,
which carry the tubP-GAL4 chromosome, were selected for dissection.
Details of the genetic scheme are available upon request.
Immunohistochemistry
Mouse anti-SYT monoclonal antibody (3H2 2D7) was obtained from the
Developmental Studies Hybridoma Bank (DSHB) (University of Iowa, IA,
USA) and used at 1:2 dilution. The anti-SYT (3H2 2D7) was originally
developed and deposited to the DSHB by Kai Zinn (Caltech), and its
speciﬁcity is described in Dubuque, et al.67 and Yoshihara and Littleton.68
Mouse anti-DGLURIIA monoclonal antibody (8B4D2) was obtained from
DSHB and used at 1:50 dilution. The anti-DGLURIIA (8B4D2) was originally
developed and deposited to the DSHB by Corey Goodman (Stanford
University), and its speciﬁcity is described in Marrus, et al.69 Mouse anti-BRP
monoclonal antibody (NC82) was obtained from DSHB and used at 1:20
dilution. The anti-BRP (NC82) was originally developed and deposited to
the DSHB by Eric Buchner (Theodor-Boveri-Institute für Biowissenschaften,
Germany), and its speciﬁcity is described in Wagh, et al.44 and Kittel, et al.43
Mouse anti-DLG monoclonal antibody (4F3) was obtained from DSHB and
used at 1:3 dilution. The anti-DLG (4F3) was originally developed and
deposited to the DSHB by Corey Goodman (Stanford University), and its
speciﬁcity has been described in Parnas, et al.70. The rabbit anti-DNRX1
antibody was originally developed and provided by David Featherstone
(university of Illinois) and used at 1:100 dilution. The speciﬁcity of the anti-
DNRX1 is described in Chen, et al.36 including the immunoreactivity tests
against the NMJs in dnrx1 null mutants. Pan-neural anti-HRP conjugated
with ﬂuorescein-isothiocyanate (Jackson ImmunoResearch, West Grove,
PA, USA) was used at 1:100 dilution, and Alexa-conjugated secondary
antibodies (Molecular probes, Eugene, OR, USA) were used at 1:1000
dilution. Confocal images were captured with Zeiss LSM510 or LSM710
microscope.
Quantiﬁcation of NMJ structure and ﬂuorescence intensity
For quantiﬁcation of synaptic phenotypes, we raised larvae at 25 ˚C and
ﬁxed at 116–120 h after egg laying and then analyzed the larval
longitudinal muscles 6/7 in the abdominal hemisegment A2 according
to the method described previously.71 Anti-HRP and anti-SYT were used to
label the neuronal termini and synaptic boutons, respectively. Total bouton
area was determined using Image-J (http://rsb.info.nih.gov/ij/) based on
anti-SYT immunoreactivity. Protein expression levels were determined with
Image-J based on ﬂuorescent intensities in the boutons using the control
and test samples processed simultaneously in the same tube. Confocal
images were captured using identical settings. Anti-HRP immunoreactivity
was used as an internal control.
Larval locomotion analysis
Wandering third instar larvae were harvested from vials using a paint
brush. The larvae were rinsed with DW and transferred to an agar plate
using a paint brush. One larva at a time was transferred to a freshly
prepared 90 mm agar plate and acclimatized until it started forward
peristalsis, then larval locomotion was ﬁlmed for 1 min at 30 frames/
second. Larval crawling speed was analyzed on the movie using a custom
Matlab (MathWorks, Natick, MA) code: a larva was segmented from the
background and larval centroid was determined every 30 frames (1 s). The
distance that the larva traveled in 1 s was calculated from the coordinates
of centroids. Larval speed (mm/sec) was calculated every 30 frames and
the highest speed that the larva scored in 1min was marked as peak
locomotion speed. Average locomotion speed (mm/min) was calculated as
total traveled distance per minute.
Statistics
Statistical analysis was performed using GraphPad Prism (GraphPad
Software, San Diego, CA) in conjunction with G*Power (University of
Düsseldorf, Düsseldorf). Experimental data were analyzed using one-way
ANOVA based on the previous studies71 without randomization and
blinding. For multiple comparisons among relevant groups, Tukey or
Dunnett’s post hoc test was used. Signiﬁcance levels in the ﬁgures are
represented as p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001
(****). Error bars in the graphs represent standard errors of means. The
statistics data are summarized in Supplementary Table S1.
Data availability
All statistical data are deposited in Supplementary Table 1, which is
available at the journal’s website. Other data sets including the confocal
images, the genetic schemes, and the behavioral programs that were
generated and/or analyzed during the current study are available from the
corresponding author on reasonable request.
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